27th Sep 2013 08:33
RNS Number : 0929P
Allergy Therapeutics PLC
27 September 2013
27 September 2013
Allergy Therapeutics plc
("Allergy Therapeutics" or the "Company")
Change of Adviser
Allergy Therapeutics, the fully integrated specialty pharmaceutical company specialising in allergy vaccines, is pleased to announce the appointment, with immediate effect, of Peel Hunt LLP as its Nominated Adviser and Broker.
-Ends-
For further information
Allergy Therapeutics | +44 (0) 1903 845 820 |
Manuel Llobet, Chief Executive Officer Ian Postlethwaite Finance Director | |
Peel Hunt LLP | +44 (0) 20 7418 8900 |
James Steel/Dr Vijay Barathan |
This information is provided by RNS
The company news service from the London Stock Exchange
Related Shares:
Allergy Thera.